DRTS on XNAS, Alpha Tau Medical Ltd., job postings
Measures activity, not value. Not investment advice.
Shares up 239% in 12 months as short interest hit 3.1M, 40 times a year earlier.
GoodNew institutional positions reached 32, 3.2 times a year earlier
BadFree cash flow was negative $32.8M over the last 12 months
Written by AI from the data on this page, 21 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 31 Dec 2025
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
–
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$42.6M
-$31.8M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.53
-$0.45
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
–
–
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-61.0%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$32.8M
-$22.0M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$76.9M
$62.9M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$6.4M
$5.6M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$70.6M (net cash)
-$57.3M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.08
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
–
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
–
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
14.1
Latest = 12 months to 31 Dec 2025; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Insider buy/sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
-$43K
bought $0, sold $43K
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+32%
96 13F filers vs 73
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
13%
11.3M shares held by 13F filers (30 Sep 2026) of 88.0M outstanding (31 Dec 2025)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
4.5%
3.9M shares sold short (30 Oct 2026) of 88.0M outstanding (31 Dec 2025)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
8.1
3.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+14%
3.4M shares sold short in the report before, 3.9M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
63%
63% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 55%
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
27
27 articles in the last 7 days; its usual week has 1.5 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
18×
27 articles in the last 7 days; its usual week has 1.5.
Unusual now sharp changes in the last 90 days, compared with its own past
New institutional positions 32, 3.2× a year earlier
Short interest 3.1M, 40× a year earlier
Price $11.76 on 20 Nov 2026, +239% over 12 months (12-month range $3.47 to $15.50)
Sharp change
Insider net buying (open market). Insiders sold a net $1.6M in the last 12 months (the 12 months before: $0).Institutional holders (13F filers). 96 13F filers reported holding it in the latest 13F quarter, +210% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, capital spending per quarter, federal obligations, lobbying spend, workers in warn layoff notices.
Made public in the last 90 days: it saw 32 13F filers open a new position in the quarter ended 30 Sep 2026, 3.2× the same quarter last year; it also had 3.1M shares sold short in the 14 Aug 2026 report, 40× the same report last year. 3 sharp changes in all.
Short interest spike: had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year Public on 10 Jun 2026.
Many funds opening a new position: saw 32 13F filers open a new position in the quarter ended 30 Sep 2026, 3.2× the same quarter last year Public on 16 Nov 2026.
Two or more unrelated kinds of records unusual within 30 days
19 May 2026confirmed
Confirmed across sources Institutional holdings and Short interest and volume
Alpha Tau Medical(DRTS): saw 20 13F filers open a new position in the quarter ended 31 Mar 2026, 4.0× the same quarter last year, while it had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year. Two unrelated kinds of activity within 49 days.
Short interest and volume: Short interest spike, became public on 25 Apr 2026
Short interest and volume: Short interest spike, became public on 12 May 2026
Institutional holdings: Many funds opening a new position, became public on 15 May 2026
Short interest and volume: Short interest spike, became public on 28 May 2026
Short interest and volume: Short interest spike, became public on 10 Jun 2026
The quarter ended 31 Mar 2026 against the 8 quarters before it.
this quarterearliernormal: 4See the evidence (5 changes)
Short interest and volume: Short interest spike became public on 25 Apr 2026
Alpha Tau Medical had 910K shares sold short in the 15 Apr 2026 report, 9.2× the same report last year.
This period
910K (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
17K
How far from its usual level
+16.0
Same report last year
99K
History used
1,492 days
the 15 Apr 2026 report24 earlier reportsnormal: 108K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 May 2026
Alpha Tau Medical had 1.0M shares sold short in the 30 Apr 2026 report, 10.0× the same report last year.
This period
1.0M (the 30 Apr 2026 report)
Normal report (median of 24 earlier)
116K
Typical spread (median absolute deviation)
25K
How far from its usual level
+18.0
Same report last year
102K
History used
1,507 days
the 30 Apr 2026 report24 earlier reportsnormal: 116K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 15 May 2026
Alpha Tau Medical saw 20 13F filers open a new position in the quarter ended 31 Mar 2026, 4.0× the same quarter last year.
This period
20 (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
4
Typical spread (median absolute deviation)
1.5
How far from its usual level
+5.3
Same quarter last year
5
History used
1,461 days
the quarter ended 31 Mar 20268 earlier quartersnormal: 4
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 28 May 2026
Alpha Tau Medical had 1.5M shares sold short in the 15 May 2026 report, 13× the same report last year.
This period
1.5M (the 15 May 2026 report)
Normal report (median of 24 earlier)
121K
Typical spread (median absolute deviation)
37K
How far from its usual level
+24.5
Same report last year
111K
History used
1,522 days
the 15 May 2026 report24 earlier reportsnormal: 121K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Jun 2026
Alpha Tau Medical had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year.
This period
1.8M (the 29 May 2026 report)
Normal report (median of 24 earlier)
127K
Typical spread (median absolute deviation)
51K
How far from its usual level
+22.0
Same report last year
97K
History used
1,536 days
the 29 May 2026 report24 earlier reportsnormal: 127K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
16 Nov 2026Institutional holdings change
saw 32 13F filers open a new position in the quarter ended 30 Sep 2026, 3.2× the same quarter last year.
Same quarter last year: 10; its normal quarter is 5.5.
See the evidence
This period
32 (the quarter ended 30 Sep 2026)
Normal quarter (median of 8 earlier)
5.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+5.1
Same quarter last year
10
History used
1,644 days
the quarter ended 30 Sep 20268 earlier quartersnormal: 5.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 3.5M shares sold short in the 15 Sep 2026 report, 26× the same report last year.
Same report last year: 132K; its normal report is 656K.
See the evidence
This period
3.5M (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
656K
Typical spread (median absolute deviation)
535K
How far from its usual level
+3.6
Same report last year
132K
History used
1,645 days
the 15 Sep 2026 report24 earlier reportsnormal: 656K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.1M shares sold short in the 14 Aug 2026 report, 40× the same report last year.
Same report last year: 77K; its normal report is 584K.
See the evidence
This period
3.1M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
584K
Typical spread (median absolute deviation)
463K
How far from its usual level
+3.6
Same report last year
77K
History used
1,613 days
the 14 Aug 2026 report24 earlier reportsnormal: 584K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.2M shares sold short in the 31 Jul 2026 report, 43× the same report last year.
Same report last year: 74K; its normal report is 551K.
See the evidence
This period
3.2M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
551K
Typical spread (median absolute deviation)
439K
How far from its usual level
+4.1
Same report last year
74K
History used
1,599 days
the 31 Jul 2026 report24 earlier reportsnormal: 551K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year.
Same report last year: 97K; its normal report is 127K.
See the evidence
This period
1.8M (the 29 May 2026 report)
Normal report (median of 24 earlier)
127K
Typical spread (median absolute deviation)
51K
How far from its usual level
+22.0
Same report last year
97K
History used
1,536 days
the 29 May 2026 report24 earlier reportsnormal: 127K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.5M shares sold short in the 15 May 2026 report, 13× the same report last year.
Same report last year: 111K; its normal report is 121K.
See the evidence
This period
1.5M (the 15 May 2026 report)
Normal report (median of 24 earlier)
121K
Typical spread (median absolute deviation)
37K
How far from its usual level
+24.5
Same report last year
111K
History used
1,522 days
the 15 May 2026 report24 earlier reportsnormal: 121K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
saw 20 13F filers open a new position in the quarter ended 31 Mar 2026, 4.0× the same quarter last year, while it had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year. Two unrelated kinds of activity within 49 days.
See the evidence (5 changes)
Short interest and volume: Short interest spike became public on 25 Apr 2026
Alpha Tau Medical had 910K shares sold short in the 15 Apr 2026 report, 9.2× the same report last year.
This period
910K (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
17K
How far from its usual level
+16.0
Same report last year
99K
History used
1,492 days
the 15 Apr 2026 report24 earlier reportsnormal: 108K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 May 2026
Alpha Tau Medical had 1.0M shares sold short in the 30 Apr 2026 report, 10.0× the same report last year.
This period
1.0M (the 30 Apr 2026 report)
Normal report (median of 24 earlier)
116K
Typical spread (median absolute deviation)
25K
How far from its usual level
+18.0
Same report last year
102K
History used
1,507 days
the 30 Apr 2026 report24 earlier reportsnormal: 116K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 15 May 2026
Alpha Tau Medical saw 20 13F filers open a new position in the quarter ended 31 Mar 2026, 4.0× the same quarter last year.
This period
20 (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
4
Typical spread (median absolute deviation)
1.5
How far from its usual level
+5.3
Same quarter last year
5
History used
1,461 days
the quarter ended 31 Mar 20268 earlier quartersnormal: 4
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 28 May 2026
Alpha Tau Medical had 1.5M shares sold short in the 15 May 2026 report, 13× the same report last year.
This period
1.5M (the 15 May 2026 report)
Normal report (median of 24 earlier)
121K
Typical spread (median absolute deviation)
37K
How far from its usual level
+24.5
Same report last year
111K
History used
1,522 days
the 15 May 2026 report24 earlier reportsnormal: 121K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Jun 2026
Alpha Tau Medical had 1.8M shares sold short in the 29 May 2026 report, 18× the same report last year.
This period
1.8M (the 29 May 2026 report)
Normal report (median of 24 earlier)
127K
Typical spread (median absolute deviation)
51K
How far from its usual level
+22.0
Same report last year
97K
History used
1,536 days
the 29 May 2026 report24 earlier reportsnormal: 127K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
15 May 2026Institutional holdings change
saw 20 13F filers open a new position in the quarter ended 31 Mar 2026, 4.0× the same quarter last year.
Same quarter last year: 5; its normal quarter is 4.
See the evidence
This period
20 (the quarter ended 31 Mar 2026)
Normal quarter (median of 8 earlier)
4
Typical spread (median absolute deviation)
1.5
How far from its usual level
+5.3
Same quarter last year
5
History used
1,461 days
the quarter ended 31 Mar 20268 earlier quartersnormal: 4
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 1.0M shares sold short in the 30 Apr 2026 report, 10.0× the same report last year.
Same report last year: 102K; its normal report is 116K.
See the evidence
This period
1.0M (the 30 Apr 2026 report)
Normal report (median of 24 earlier)
116K
Typical spread (median absolute deviation)
25K
How far from its usual level
+18.0
Same report last year
102K
History used
1,507 days
the 30 Apr 2026 report24 earlier reportsnormal: 116K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 910K shares sold short in the 15 Apr 2026 report, 9.2× the same report last year.
Same report last year: 99K; its normal report is 108K.
See the evidence
This period
910K (the 15 Apr 2026 report)
Normal report (median of 24 earlier)
108K
Typical spread (median absolute deviation)
17K
How far from its usual level
+16.0
Same report last year
99K
History used
1,492 days
the 15 Apr 2026 report24 earlier reportsnormal: 108K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 771K shares sold short in the 31 Mar 2026 report, 8.8× the same report last year.
Same report last year: 88K; its normal report is 104K.
See the evidence
This period
771K (the 31 Mar 2026 report)
Normal report (median of 24 earlier)
104K
Typical spread (median absolute deviation)
16K
How far from its usual level
+13.4
Same report last year
88K
History used
1,477 days
the 31 Mar 2026 report24 earlier reportsnormal: 104K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 574K shares sold short in the 13 Mar 2026 report, 4.7× the same report last year.
Same report last year: 122K; its normal report is 104K.
See the evidence
This period
574K (the 13 Mar 2026 report)
Normal report (median of 24 earlier)
104K
Typical spread (median absolute deviation)
16K
How far from its usual level
+9.4
Same report last year
122K
History used
1,459 days
the 13 Mar 2026 report24 earlier reportsnormal: 104K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 595K shares sold short in the 27 Feb 2026 report, 7.8× the same report last year.
Same report last year: 76K; its normal report is 102K.
See the evidence
This period
595K (the 27 Feb 2026 report)
Normal report (median of 24 earlier)
102K
Typical spread (median absolute deviation)
16K
How far from its usual level
+9.9
Same report last year
76K
History used
1,445 days
the 27 Feb 2026 report24 earlier reportsnormal: 102K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 655K shares sold short in the 13 Feb 2026 report, 8.7× the same report last year.
Same report last year: 75K; its normal report is 100K.
See the evidence
This period
655K (the 13 Feb 2026 report)
Normal report (median of 24 earlier)
100K
Typical spread (median absolute deviation)
16K
How far from its usual level
+11.1
Same report last year
75K
History used
1,431 days
the 13 Feb 2026 report24 earlier reportsnormal: 100K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 658K shares sold short in the 30 Jan 2026 report, 6.5× the same report last year.
Same report last year: 102K; its normal report is 100K.
See the evidence
This period
658K (the 30 Jan 2026 report)
Normal report (median of 24 earlier)
100K
Typical spread (median absolute deviation)
12K
How far from its usual level
+11.2
Same report last year
102K
History used
1,417 days
the 30 Jan 2026 report24 earlier reportsnormal: 100K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 527K shares sold short in the 15 Jan 2026 report, 4.1× the same report last year.
Same report last year: 130K; its normal report is 100K.
See the evidence
This period
527K (the 15 Jan 2026 report)
Normal report (median of 24 earlier)
100K
Typical spread (median absolute deviation)
12K
How far from its usual level
+8.5
Same report last year
130K
History used
1,402 days
the 15 Jan 2026 report24 earlier reportsnormal: 100K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Not listed: 14 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001871321
Ticker
DRTS
Domain
alphatau.com
Hq location
L3|JERUSALEM|97776 (1 unverified)
Name
Alpha Tau Medical Ltd.
SEC Form 13F institutional holdings171 data points31 Mar 2022 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)5 records28 Mar 2022 to 9 Mar 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)87 data points31 Dec 2018 to 31 Dec 2025
SEC Form 4 insider transactions9 records, 36 data points4 Jun 2026 to 25 Aug 2026
FINRA short interest (twice monthly)335 data points15 Mar 2022 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)2366 data points8 Mar 2022 to 20 Nov 2026